Drug record
What four public record sets show for amoxicillin. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.068 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $29.3 million | Details |
| FDA recall records | 20 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Amoxicillin 250 Mg Capsule: pharmacies pay about $0.068 each, or $2.05 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| AMOXICILLIN 125 MG TAB CHEW | Generic | $0.209 per each | $6.27 | Oct 21, 2026 |
| AMOXICILLIN 125 MG/5 ML SUSP | Generic | $0.018 per mL | — | Oct 21, 2026 |
| AMOXICILLIN 200 MG/5 ML SUSP | Generic | $0.037 per mL | — | Oct 21, 2026 |
| AMOXICILLIN 250 MG CAPSULE | Generic | $0.068 per each | $2.05 | Oct 21, 2026 |
| AMOXICILLIN 250 MG TAB CHEW | Generic | $0.300 per each | $8.99 | Oct 21, 2026 |
| AMOXICILLIN 250 MG/5 ML SUSP | Generic | $0.024 per mL | — | Oct 21, 2026 |
| AMOXICILLIN 400 MG/5 ML SUSP | Generic | $0.034 per mL | — | Oct 21, 2026 |
| AMOXICILLIN 500 MG CAPSULE | Generic | $0.079 per each | $2.38 | Oct 21, 2026 |
| AMOXICILLIN 500 MG TABLET | Generic | $0.089 per each | $2.68 | Oct 21, 2026 |
| AMOXICILLIN 875 MG TABLET | Generic | $0.154 per each | $4.63 | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $29.3 million for the 1 product below. That is up 3% from $28.3 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Amoxicillin Amoxicillin | $29.3 million | 6,486,159 | $3.10 | $4.52 | $28.3 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year. Not counted here, combination products that contain it: Amoxicillin-Clavulanate Pot ER, Amoxicillin-Clavulanate Potass, Augmentin, Voquezna Dual Pak, Voquezna Triple Pak.
Recalls reported to the FDA that name this drug.
The FDA has 20 recall records that name amoxicillin in the product description (15 Class II · 5 Class III). 2 are still marked ongoing.
Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
Reason: Subpotent drug; Clavulanate Potassium component
Amoxicillin and Clavulanate Potassium Tablets USP, Chewable 400mg/57mg, 20-count bottles, Rx only, Manufactured in Canada By: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0093-2272-34
Reason: Subpotent Drug
AMOXICILLIN Tablets, USP, 875MG, 20 Tablets, Rx Only, Manufactured by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540. NDC: 0781-5060-20
Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454. NDC: 0093-4161-73
Reason: CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Amoxicillin Capsules, USP, 500 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0781-2613-01
Reason: cGMP deviations: Temperature abuse
AMOXICILLIN 500MG 100; NDC/UPC 65862001401; RX; TABLETS
Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Amoxicillin and Clavulanate Potassium Tablets, USP, 875 mg/125 mg, 20-count bottles, Distributed by: Aurobindo Pharma USA. Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Made in India; NDC 65862-503-20
Reason: Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie
Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in (a) 150 mL bottle (NDC 0093-4150-80) (b) 80 mL bottle (NDC 0093-4150-79), Rx Only, Manufactured in Canada By: Teva Canada Limited Toronto, Canada, M1B2K9, Manufactured For: Teva Pharmaceuticals USA, INC. North Wales, PA 19454.
Reason: Subpotent Product: assay results for Amoxicillin were below the specification limits.
Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted) bottle, Rx Only, Manufactured By: Cipla Ltd. at Medispray Laboratories Pvt. Ltd., Kundaim Goa, India; Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054, NDC 60432-065-00.
Reason: Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.
Amoxicillin and Clavulanate Potassium Tablets, USP, 500 mg/125 mg, in 20 count bottles, Rx Only, Manufactured in Austria by Sandoz Gmbh for Sandoz Inc. Princeton NJ NDC 0781-1831-20
Reason: Subpotent Drug; Clavulanic Acid
Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73
Reason: Subpotency: due to a low, out of specification test result for assay during stability testing.
Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 183400, Amman 11118 - Jordan, NDC 0143-9887-01
Reason: Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for amoxicillin. This page is public-record information, not medical advice.